Deciphering ion transporters, kinases and PDZ-adaptor molecules that mediate guanylate cyclase C agonist-dependent intestinal fluid loss in vivo

Yongjian Liu(Hebei Medical University), Ursula Seidler(Medizinische Hochschule Hannover), Gabriella Di Stefano(Medizinische Hochschule Hannover), Brigitte Riederer(Medizinische Hochschule Hannover), Dorothee Römermann(Medizinische Hochschule Hannover), Johannes Reiner(Albany Medical Center Hospital), Jiajie Qian(Medizinische Hochschule Hannover), Qinghai Tan(Tongji Hospital)
Biochemical Pharmacology
May 15, 2020
10.1016/j.bcp.2020.114040
Cited by 15

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409